Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment

Arlette Bruijstens; Katelijn Blok; Jill Smolders; Beatrijs Wokke; Rinze Neuteboom

doi:10.1177/1352458520921367

Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment

Arlette Bruijstens^*, Katelijn Blok, Jill Smolders, Beatrijs Wokke, Rinze Neuteboom

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Article › Academic › peer-review

6 Downloads (Pure)

Original language	English
Pages (from-to)	1962-1964
Number of pages	3
Journal	Multiple Sclerosis Journal
Volume	26
Issue number	14
DOIs	https://doi.org/10.1177/1352458520921367
Publication status	Published - Dec 2020

Bibliographical note

Funding:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was supported by the
Dutch MS research Foundation.

Access to Document

10.1177/1352458520921367Licence: CC BY-NC

Repub_127220_O-A.pdfFinal published version, 444 KBLicence: CC BY-NC

Cite this

@article{0e0ae6a418384e14be0df05e7b9bfd6b,

title = "Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment",

author = "Arlette Bruijstens and Katelijn Blok and Jill Smolders and Beatrijs Wokke and Rinze Neuteboom",

note = "Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was supported by the Dutch MS research Foundation.",

year = "2020",

month = dec,

doi = "10.1177/1352458520921367",

language = "English",

volume = "26",

pages = "1962--1964",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "14",

}

TY - JOUR

T1 - Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment

AU - Bruijstens, Arlette

AU - Blok, Katelijn

AU - Smolders, Jill

AU - Wokke, Beatrijs

AU - Neuteboom, Rinze

N1 - Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was supported by the Dutch MS research Foundation.

PY - 2020/12

Y1 - 2020/12

U2 - 10.1177/1352458520921367

DO - 10.1177/1352458520921367

M3 - Article

C2 - 32406801

SN - 1352-4585

VL - 26

SP - 1962

EP - 1964

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

IS - 14

ER -